Evidence map›Paper›PMID 42195150›Full record

Observational studyMedicina (Kaunas, Lithuania)2026

Outer Retinal Hyperreflective Foci as a Predictor of Hyperreflective Material Boundary Remodeling and Visual Outcomes in Neovascular Age-Related Macular Degeneration.

Mihailo Jovanović, Jelena Milošević, Marta Carrasco Guijarro, Svetlana Jovanović, Dušan Todorović, Nenad Petrović, Svetlana Paunović, Katarina Janićijević, Maja L J Živković

Abstract readObservational Study
In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mihailo JovanovićUniversity of Kragujevac, Faculty of Medical Sciences, Department of Ophthalmology, Svetozara Markovića 69, 34000 Kragujevac, Serbia.ORCID 0000-0001-5315-8053
Jelena MiloševićUniversity of Kragujevac, Faculty of Medical Sciences, Department of Clinical and Experimental Surgery, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Marta Carrasco GuijarroCentro de Oftalmología Barraquer, 08021 Barcelona, Spain.
Svetlana JovanovićUniversity of Kragujevac, Faculty of Medical Sciences, Department of Ophthalmology, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Dušan TodorovićUniversity of Kragujevac, Faculty of Medical Sciences, Department of Ophthalmology, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Nenad PetrovićUniversity of Kragujevac, Faculty of Medical Sciences, Department of Ophthalmology, Svetozara Markovića 69, 34000 Kragujevac, Serbia.ORCID 0009-0004-3872-8803
Svetlana PaunovićUniversity of Kragujevac, Faculty of Medical Sciences, Department of Ophthalmology, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Katarina JanićijevićUniversity of Kragujevac, Faculty of Medical Sciences, Department of Social Medicine, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Maja L J ŽivkovićDepartment of Ophthalmology, Faculty of Medicine, University of Niš, Bulevar dr. Zorana Đinđića 81, 18000 Niš, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Macular DegenerationRetinaAgedAged, 80 and overAngiogenesis InhibitorsBevacizumabFemaleHumansIntravitreal InjectionsMaleRetrospective StudiesTomography, Optical CoherenceTreatment OutcomeVisual AcuityAngiogenesis InhibitorsBevacizumabanti-VEGFbevacizumabboundary remodelinghyperreflective focihyperreflective materialneovascular age-related macular degenerationoptical coherence tomographytreat and extend

Identifiers

PMID42195150
PMCPMC13208177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.